|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.50 CHF | +0.14% |
|
-1.33% | +4.49% |
| 02:22pm | Europe's Key Companies – Telenor Jumps 8.1 Percent | FW |
| 21/01 | Zura Bio Appoints Sandeep Kulkarni as CEO | MT |
Chart calendar Novartis AG
Upcoming events on Novartis AG
| 04/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 04/02/2026 | Q4 2025 Earnings Call | Add to your calendar Google Apple ICS format |
| 03/03/2026 | TD Cowen Healthcare Conference | Add to your calendar Google Apple ICS format |
| 04/03/2026 | UBS European Healthcare Conference | Add to your calendar Google Apple ICS format |
| 06/03/2026 | Annual General Meeting | Add to your calendar Google Apple ICS format |
| 10/03/2026 | Barclays Global Healthcare Conference | Add to your calendar Google Apple ICS format |
| 24/03/2026 | BNP Paribas Exane Healthcare Conference | Add to your calendar Google Apple ICS format |
| 28/04/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 21/07/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 03/11/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 03/02/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Novartis AG
| 12/01/2026 | J.P. Morgan Healthcare Conference |
| 12/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-08 |
| 12/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-15 |
| 12/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-08-27 |
| 11/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PD5-10 |
| 11/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS1-04-17 |
| 11/12/2025 | San Antonio Breast Cancer Symposium - Abstract No - # PS1-10-27 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No - #LBA-2 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No - #4981 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No - #4978 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No - #5549 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No - #906 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No - #910 |
| 09/12/2025 | American Society of Hematology Meeting - Abstract No - #844 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #3198 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #670 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #724 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No - #1997 |
| 04/12/2025 | Berenberg European Conference |
| 04/12/2025 | Citi Global Healthcare Conference |
Past dividends on Novartis AG
| 11/03/2025 | Annual 3.5 CHF |
| 07/03/2024 | Annual 3.3 CHF |
| 09/03/2023 | Annual 3.2 CHF |
| 08/03/2022 | Annual 3.1 CHF |
| 04/03/2021 | Annual 3 CHF |
| 03/03/2020 | Annual 2.95 CHF |
| 04/03/2019 | Annual 2.85 CHF |
| 06/03/2018 | Annual 2.8 CHF |
| 02/03/2017 | Annual 2.75 CHF |
| 25/02/2016 | Annual 2.7 CHF |
| 03/03/2015 | 2.6 CHF |
| 27/02/2014 | Annual 2.45 CHF |
| 26/02/2013 | Annual 2.3 CHF |
| 27/02/2012 | Annual 2.25 CHF |
| 24/02/2011 | Annual 2.2 CHF |
| 02/03/2010 | Annual 2.1 CHF |
| 27/02/2009 | Annual 2 CHF |
| 29/02/2008 | Annual 1.6 CHF |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 50 545 51 352 -1.57% | 46 660 46 810 -0.32% | 51 722 50 407 2.61% | 55 605 | 57 020 | 59 367 |
|
EBITDA Million USD | Released Forecast Spread | 18 613 17 036 9.25% | 17 937 18 223 -1.57% | 21 006 19 819 5.99% | 23 727 | 23 638 | 25 010 |
|
EBIT Million USD | Released Forecast Spread | 16 665 16 417 1.51% | 16 372 16 735 -2.17% | 19 494 18 983 2.69% | 21 845 | 21 884 | 23 209 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8 371 10 562 -20.74% | 9 123 10 323 -11.63% | 13 640 13 560 0.59% | 17 360 | 17 807 | 19 047 |
|
Net income Million USD | Released Forecast Spread | 6 955 8 563 -18.78% | 14 854 10 329 43.8% | 11 939 11 438 4.38% | 14 214 | 14 247 | 15 577 |
|
EPS USD | Released Forecast Spread | 3,19 4,06 -21.46% | 7,15 5,38 32.95% | 5,92 5,53 7% | 7,16 | 7,40 | 8,07 |
| Announcement Date | 01/02/23 | 31/01/24 | 31/01/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12 120 11 498 5.41% | 12 872 12 319 4.49% | 13 172 12 666 4% | 13 558 12 823 5.73% | 13 620 13 116 3.85% | 14 836 14 136 4.95% | 14 358 13 866 3.55% | 13 805 | 13 723 | 14 162 | 14 335 | 14 110 |
|
EBITDA Million USD | Released Forecast Spread | 5 294 | 4 861 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | 4 537 4 220 7.52% | 4 953 4 667 6.12% | 5 145 4 892 5.16% | 4 859 4 435 9.56% | 5 575 5 272 5.75% | 5 925 5 827 1.68% | 5 460 5 520 -1.08% | 4 853 | 5 604 | 5 552 | 5 371 | 4 807 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 129 3 453 -9.38% | 3 841 3 896 -1.41% | 3 385 4 028 -15.96% | 3 285 3 478 -5.55% | 4 196 4 238 -0.99% | |||||||
|
Net income Million USD | Released Forecast Spread | 2 688 2 459 9.31% | 3 246 2 858 13.59% | 3 189 3 197 -0.25% | 2 820 2 585 9.08% | 3 606 3 255 10.78% | 4 024 3 909 2.93% | 3 930 3 652 7.61% | 2 414 | 3 350 | 3 690 | 3 590 | 3 381 |
|
EPS USD | Released Forecast Spread | 1,31 1,19 10.18% | 1,60 1,40 14.13% | 1,58 1,48 7.03% | 1,42 1,30 9.63% | 1,83 1,65 10.96% | 2,07 1,99 3.77% | 2,04 1,87 9.02% | 1,26 | 1,75 | 1,93 | 1,87 | 1,77 |
| Announcement Date | 23/04/24 | 18/07/24 | 29/10/24 | 31/01/25 | 29/04/25 | 17/07/25 | 28/10/25 | - | - | - | - | - |
| 23/01/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 23/01/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 29/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 29/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 29/01/2026 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for Novartis AG
| Today | Q3 2026 Earnings Release (Projected) | |
| Today | Q3 2026 Earnings Release | |
| 21/01/2026 | Q3 2026 Earnings Release | |
| 21/01/2026 | Q4 2025 Earnings Release | |
| 21/01/2026 | Q4 2025 Earnings Release | |
| 16/01/2026 | Q3 2026 Earnings Release | |
| 16/01/2026 | Q3 2026 Earnings Release (Projected) | |
| 12/01/2026 | December 2025 Sales and Revenue Release | |
| 10/01/2026 | December 2025 Sales and Revenue Release | |
| 09/01/2026 | December 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
- Calendar Novartis AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















